絞り込み

16758

広告

福島第一原発 首都圏から社員移動させず 感染拡大防止へ対策 (NHK)

新型コロナウイルスの感染が全国的に拡大し緊急事態宣言が東京都などに出される中、東京電力・福島第一原子力発電所では、感染が広がって廃炉作業が滞らないよう、原則とし...

  1. 厚生科学審議会 (予防接種・ワクチン分科...
  2. スパコン「富岳」を治療薬開発に活用…「最...
  3. 第23回厚生科学審議会予防接種・ワクチン...
  4. 令和2年度厚生労働省補正予算案の概要

ニュース一覧

Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities.

著者 Brown V , Peciña M
Front Psychiatry.2019 ; 10():669.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (2view , 0users)

Full Text Sources

Over the last two decades, neuroscientists have used antidepressant placebo probes to examine the biological mechanisms implicated in expectancies of mood improvement.However, findings from these studies have yet to elucidate a model-based theory that would explain the mechanisms through which antidepressant expectancies evolve to induce persistent mood changes. Compared to other fields, the development of experimental models of antidepressant placebo effects faces significant challenges, such as the delayed mechanism of action of conventional antidepressants and the complex internal dynamics of mood. Still, recent neuroimaging studies of antidepressant placebo effects have shown remarkable similarities to those observed in other disciplines (e.g., placebo analgesia), such as placebo-induced increased µ-opioid signaling and blood-oxygen-level dependent (BOLD) responses in areas involved in cognitive control, the representation of expected values and reward and emotional processing. This review will summarize these findings and the challenges and opportunities that arise from applying methodologies used in the field of placebo analgesia into the field of antidepressant placebo effects.
PMID: 31616327 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード